p38γ/MAPK12 Antibody (Rabbit mAb) [F12K4]

Application: Reactivity: Rat, Human

Usage Information

Dilution
WB1:1000 IF1:500

Application
WB, IF

Reactivity
Rat, Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
42 kDa 42 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
p38γ/MAPK12 Antibody (Rabbit mAb) [F12K4] detects endogenous levels of total p38γ/MAPK12 protein.

Clone
F12K4

Synonym(s)
ERK6, SAPK3, MAPK12, Mitogen-activated protein kinase 12, MAP kinase 12, MAPK 12, Extracellular signal-regulated kinase 6, Stress-activated protein kinase 3, ERK-6, MAP kinase p38 gamma

Background
p38 gamma, encoded by MAPK12 and also designated SAPK3, belongs to the p38 subfamily of mitogen-activated protein kinases alongside p38 alpha, beta, and delta, and functions as a serine/threonine kinase within the stress-activated MAPK signaling module that relays extracellular signals from MKK3 and MKK6 toward downstream effectors. What sets p38 gamma apart structurally from the other p38 isoforms is a short C-terminal -KETXL sequence that forms a PDZ-binding motif, a feature absent from p38 alpha, beta, and delta; this motif directs p38 gamma toward a distinct set of PDZ-domain-containing substrates rather than the classical p38 targets MAPKAP-K2 and MAPKAP-K3, which p38 gamma and delta cannot phosphorylate. Through this PDZ-mediated docking, p38 gamma binds and phosphorylates scaffold proteins including alpha-1-syntrophin, PSD-95/SAP90, and SAP97/hDlg, proteins normally anchored at specialized membrane sites such as the neuromuscular junction, and this interaction modulates the localization and activity of the cytoskeletal scaffold rather than acting through a diffuse cytoplasmic signal. p38 gamma also engages the phosphatase PTPH1 through the same PDZ-mediated mechanism, and this reciprocal relationship runs in both directions: PTPH1 binds and dephosphorylates p38 gamma to inactivate it, while activated p38 gamma phosphorylates PTPH1 in turn, and this bidirectional PDZ-coupled complex operates in a stage-specific manner during Ras-driven transformation, with PTPH1-mediated dephosphorylation of p38 gamma supporting early proliferative changes and p38 gamma-mediated phosphorylation of PTPH1 sustaining the malignant, invasive phenotype at later stages. Removing either the PDZ motif of p38 gamma or the PDZ domain of PTPH1 eliminates both the binding interaction and the oncogenic cooperation between the two proteins, establishing PDZ-mediated docking as the structural requirement for their coordinated signaling rather than kinase activity alone, since p38 gamma is known to act as a Ras effector independent of its own phosphorylation state in certain contexts. Ras signaling increases expression of both p38 gamma and PTPH1, and primary colon cancer tissue shows a coupling between elevated p38 gamma expression and altered PTPH1 levels, linking this kinase-phosphatase network directly to tumor tissue biology rather than to cultured cell models alone. p38 gamma is expressed prominently in skeletal muscle and heart, and its PDZ-mediated docking mechanism, combined with its distinct substrate specificity relative to the other p38 isoforms, positions it as a structurally and functionally separable node within stress-activated MAPK signaling, one that researchers can target through disruption of the PDZ interaction itself rather than through conventional kinase-active-site inhibition.

Background

p38 gamma, encoded by MAPK12 and also designated SAPK3, belongs to the p38 subfamily of mitogen-activated protein kinases alongside p38 alpha, beta, and delta, and functions as a serine/threonine kinase within the stress-activated MAPK signaling module that relays extracellular signals from MKK3 and MKK6 toward downstream effectors. What sets p38 gamma apart structurally from the other p38 isoforms is a short C-terminal -KETXL sequence that forms a PDZ-binding motif, a feature absent from p38 alpha, beta, and delta; this motif directs p38 gamma toward a distinct set of PDZ-domain-containing substrates rather than the classical p38 targets MAPKAP-K2 and MAPKAP-K3, which p38 gamma and delta cannot phosphorylate. Through this PDZ-mediated docking, p38 gamma binds and phosphorylates scaffold proteins including alpha-1-syntrophin, PSD-95/SAP90, and SAP97/hDlg, proteins normally anchored at specialized membrane sites such as the neuromuscular junction, and this interaction modulates the localization and activity of the cytoskeletal scaffold rather than acting through a diffuse cytoplasmic signal. p38 gamma also engages the phosphatase PTPH1 through the same PDZ-mediated mechanism, and this reciprocal relationship runs in both directions: PTPH1 binds and dephosphorylates p38 gamma to inactivate it, while activated p38 gamma phosphorylates PTPH1 in turn, and this bidirectional PDZ-coupled complex operates in a stage-specific manner during Ras-driven transformation, with PTPH1-mediated dephosphorylation of p38 gamma supporting early proliferative changes and p38 gamma-mediated phosphorylation of PTPH1 sustaining the malignant, invasive phenotype at later stages. Removing either the PDZ motif of p38 gamma or the PDZ domain of PTPH1 eliminates both the binding interaction and the oncogenic cooperation between the two proteins, establishing PDZ-mediated docking as the structural requirement for their coordinated signaling rather than kinase activity alone, since p38 gamma is known to act as a Ras effector independent of its own phosphorylation state in certain contexts. Ras signaling increases expression of both p38 gamma and PTPH1, and primary colon cancer tissue shows a coupling between elevated p38 gamma expression and altered PTPH1 levels, linking this kinase-phosphatase network directly to tumor tissue biology rather than to cultured cell models alone. p38 gamma is expressed prominently in skeletal muscle and heart, and its PDZ-mediated docking mechanism, combined with its distinct substrate specificity relative to the other p38 isoforms, positions it as a structurally and functionally separable node within stress-activated MAPK signaling, one that researchers can target through disruption of the PDZ interaction itself rather than through conventional kinase-active-site inhibition.

References
https://pubmed.ncbi.nlm.nih.gov/30109176/ https://pubmed.ncbi.nlm.nih.gov/20332238/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%